The State of the Insurance Tech Market: What MGAs and Carrier Underwriting Teams Actually Need to Buy in 2026

A note before we get into the numbers. I’ve been wanting to write this piece for a while, and I kept holding off because the market keeps moving fast enough that any analysis risks being stale by the time it hits LinkedIn. Then I realized that’s exactly the point. The pace of change in insurance technology right now is the story. The carriers and MGAs I talk to every week are making platform decisions that will define their next five years, and the analysis available to them is either a vendor pitch deck dressed up as thought leadership or a consultancy report written by people who have never actually had to make one of these decisions. There’s a gap in the middle, and that’s what this piece is trying to fill.

What follows is my honest read of where the insurance tech market sits in 2026. The vendors I name are vendors I’ve studied, demoed, competed against, sold alongside, and in some cases referred customers to. The buyers I describe are the people I’ve sat across the table from in conference rooms in New York, London, and a dozen other cities. The frameworks I lay out are the same ones I use when I’m helping an MGA principal think through a platform decision or when I’m advising a founder on how to position into this market. I have opinions. They’re informed. I’ll share them directly, and where I think the conventional wisdom is wrong, I’ll say so. If you disagree with any of it, I genuinely want to hear why. The market is too important and moving too fast for any of us to have the complete picture, and the best analysis comes out of operators arguing in good faith.

With that out of the way, let’s start with what the numbers actually look like.

Insurtech funding climbed 19.5 percent in 2025 to $5.08 billion, the sector's first annual gain since 2021. Two-thirds of that capital, roughly $3.35 billion across 227 deals, flowed into AI-focused companies. The number of mega-rounds above $100 million nearly doubled, jumping from six to eleven. Federato closed a $100 million Series D led by Goldman Sachs Asset Management in November 2025, taking total funding to $182 million. Corgi raised $108 million to launch a full-stack AI-native carrier. Sixfold closed a $30 million Series B led by Brewer Lane with strategic backing from Guidewire Software in January 2026. Applied Systems acquired Cytora in September 2025. CyberCube, ICEYE , and Nirvana Insurance all joined the mega-round club.

Capital is flowing. That part is obvious. What's less obvious, and what most of the coverage misses, is what's actually happening on the buyer side. Because the carriers and MGAs writing the checks for these platforms are making decisions based on operational realities that most of the funding analysis ignores. Those realities determine which platforms scale into durable franchises and which ones become acquisition fodder or footnotes.

I've spent over a decade building and operating in this market. I've led enterprise sales motions selling underwriting and distribution platforms into MGAs, large carriers, and specialty programs. I've sat in the room as underwriting leaders debated build versus buy. I've watched insurtech sales cycles stretch from months to years and then collapse the moment a vendor finally understood what the buyer was actually evaluating. I've also been on the product side, building and scaling SaaS platforms in this space at companies including ScholarusAI and Hogglet, so I understand both sides of the table: what it takes to ship product that wins in production, and what it takes to convince a buyer to put it there.

This analysis is based on that operating experience. It is a map of where the market is, where the capital is going, and what the people writing the checks are actually looking for. Because the gap between what insurtech vendors think MGAs and carriers want, and what those buyers actually need, is wider than the funding numbers suggest, and the vendors that close that gap in the next 24 months will define the next decade of this category.

The Macro Picture: B2B Has Won

The most important shift in insurtech over the last three years is the death of the direct-to-consumer disruption thesis. The Lemonades, Roots, and Hippos of the world are not dead, but the investor narrative has clearly moved on. B2B tech vendors now represent 58 percent of P&C insurtech deals, a 12 percentage point increase from the 2021 boom. The share going to lead generators, brokers, and consumer-facing MGAs fell to 35 percent, the lowest level on record.

Re/insurers completed 162 private technology investments in insurtech companies during 2025, more than any prior year on record. That's not Silicon Valley VCs chasing growth. That's incumbent capital backing the operating models they want to learn from. Travelers acquired Corvus by Travelers. Allianz X backed Openly. Munich Re acquired Next Insurance for $2.6 billion in March 2025. Applied Systems acquired Cytora in September 2025. These are not bets on disruption. They are bets on absorption.

The implication for anyone selling into this market is straightforward. The buyer is no longer a startup trying to replace incumbent infrastructure. The buyer is the incumbent, looking for technology that fits inside an existing operating model and produces measurable improvements within an 18-month window. Andrew Johnston, Gallagher Re's global head of insurtech, has been blunt about this: insurtech and AI will eventually be synonymous, because every insurer is becoming a technology business. The category is collapsing into infrastructure.

The MGA Market: Where the Real Spending Is Happening

Direct premium written by US MGAs hit $114.1 billion in 2024, a 16 percent increase year over year, outpacing the broader P&C market. The sector has more than doubled in size over the past several years, tracking the growth of the E&S market. There are now more than 1,000 MGAs in the US, and the segment has produced double-digit premium growth for four consecutive years. Fronting carriers supported more than $18 billion in MGA premium in 2024, up 26 percent over the prior year. Roughly 20 percent of total MGA premium is now backed by fronting carriers.

This is the buyer pool that most insurtech platforms are chasing, and for good reason. MGAs are structurally faster to adopt new technology than traditional carriers. They are smaller, more entrepreneurial, less burdened by legacy systems, and competitively pressured to differentiate through speed and specialization. They also have one critical buying constraint that vendors consistently misread: they answer to capacity partners.

An MGA cannot deploy a new underwriting platform without confidence that their capacity providers will accept the output. Jascha Prosiegel, who oversees Munich Re Specialty's insurtech programs, has been explicit about what reinsurers are evaluating when they look at tech-forward MGAs. It's not the sophistication of the algorithm. It's the discipline of the book. Capacity partners want to know whether an MGA is building a sustainable, profitable program or running a tech experiment they might pivot away from next year. That question gets answered by the operating fundamentals, not the AI feature set.

So when a platform vendor walks into an MGA pitch leading with reinforcement learning and federated data graphs, they are answering a question the principal isn't asking. The principal is asking: will this platform help me sign a deeper capacity deal, expand my appetite, and demonstrate underwriting discipline to my reinsurer? If the vendor can't answer that question in the buyer's own language, the demo ends politely and the deal dies in legal review. I've watched this exact scenario play out enough times to know it's the rule, not the exception.

The Underwriting Platform Category: Crowded and Converging

Datos Insights' most recent underwriting workbench market navigator profiles 21 leading vendors serving the North American P&C market. The list includes Appian, Convr, Duck Creek Technologies , Federato, Guidewire, hyperexponential, Insurity, INSILLION, intellectAI , Jarus, Kalepa , mea Platform, Pibit.AI, Sapiens AdvantageGo, Salesforce , Send, Sixfold, TinBu LLC , Unqork , Virtusa, and Weav.ai. That's before you add in the recently acquired (Cytora into Applied) and the AI-native intake platforms positioning themselves alongside the workbench category.

Every one of these platforms has a slightly different positioning narrative, but the category has compressed into a feature parity race where the actual differentiation is harder to articulate from a marketing page than it used to be. Let me walk through the key players and where they actually fit, because the buyer needs a real map of this landscape and most of the analyst coverage flattens distinctions that matter operationally.

Federato

Federato has been the most aggressive at positioning its platform as a category of one. RiskOps as a framework emphasizes portfolio alignment with day-to-day underwriting actions, supported by a federated data graph and AI-driven next-best-action recommendations. The platform claims 90 percent improvement in time to quote, 3x improvement in the proportion of good business bound, and 50 to 90 percent reduction in systems used by underwriters. Founded in 2020, the company has raised $182 million across four rounds, with the most recent being a $100 million Series D led by Goldman Sachs Asset Management in November 2025, joined by Emergence Capital, Caffeinated Capital, StepStone, and Pear VC.

Customer roster spans global carriers, MGAs, and mutuals across both commercial and personal lines, with stated focus areas including wildfire insurance, commercial trucking, and specialty programs. The company has tripled its customer base across funding rounds and reports doubled spend within existing customers, which are the metrics that actually matter for SaaS durability. Federato is real, well-funded, and has earned its seat at the table. The category compression problem applies to Federato as much as anyone else, but they have more runway to navigate it than most.

hyperexponential

If Federato owns the portfolio-and-workbench narrative, hyperexponential owns the pricing and rating decision intelligence narrative. The London-based company, founded in 2017, has built hx Renew, a code-first pricing platform that brings software engineering rigor to actuarial modeling. The thesis is sharp: pricing models are software, but insurers manage them like documents. hx Renew applies version control, testing, and CI/CD discipline to actuarial work, replacing the fifty-tab Excel spreadsheets that still run most specialty pricing operations.

Customer roster is the proof point. Convex, Hiscox, AXA XL, Beazley, Inigo, AEGIS London, and a broader set of Lloyd's syndicates and London market carriers. AEGIS London writes more than $1 billion of gross written premium across property, casualty, specialty, and marine and energy lines. The fact that hyperexponential displaced a custom-built platform with 58 individual pricing models inside a top-quartile Lloyd's syndicate is operationally significant. It tells you something about the platform's ability to handle real complexity at scale, not just demo well in a sales cycle.

Where hyperexponential's positioning gets interesting is the boundary with platforms like Earnix and WTW Radar, which dominate personal lines price optimization. hyperexponential has been deliberate about staying in specialty and reinsurance, where underwriter judgment matters and pricing models are bespoke. That discipline is what gives them their differentiation. The risk is the same one Federato faces: as competitors layer in agentic AI and modeling automation, the differentiation between code-first pricing platforms and AI-assisted workbenches narrows.

Sixfold

Sixfold has taken a different approach from either Federato or hyperexponential. The New York-based company, founded in 2022 and led by Alex Schmelkin and Jane Tran, has built what they call the AI Underwriter. The platform ingests underwriting guidelines, extracts relevant risk data, and surfaces tailored insights to drive faster, more consistent decisions. The differentiator is the autonomous agent architecture. Sixfold's agents triage cases, research, write referrals, update documentation, and move cases forward without continuous underwriter intervention.

Customer adoption is where Sixfold's story gets compelling. Zurich North America deployed the platform across its entire middle market underwriting team of more than 200 underwriters, reporting up to two hours saved per submission. Skyward Specialty deployed Sixfold across 11 underwriting teams and reduced quote response time by an average of 35 percent. AXIS is also a public customer. The company closed a $30 million Series B in January 2026 led by Brewer Lane with strategic participation from Guidewire and existing investors Bessemer Venture Partners and Salesforce Ventures. Total funding now stands at $52 million.

The Guidewire strategic investment matters in ways that aren't obvious from a press release. Guidewire sits at the core of policy administration for a huge percentage of the P&C market. A strategic partnership creates integration economics that pure-play AI vendors don't have. Sixfold has positioned itself as the AI brain that handles submissions while underwriters focus on strategy, which is a smart framing because it doesn't pick a fight with the workbench category directly. It plugs into it.

Kalepa

Kalepa, founded in 2018 in New York, has built a more focused product called Copilot. The platform extracts data from loss runs, ACORD forms, and supplemental applications, then surfaces opportunities and risks to underwriters. Customer roster includes Bowhead Specialty, which selected Kalepa after what the company described as a rigorous evaluation of market alternatives. Bowhead is a serious specialty carrier with a sophisticated underwriting culture, and the public endorsement carries weight. Kalepa serves carriers, MGAs, and reinsurers with what they call professional grade AI built specifically for insurance.

Kalepa's positioning is interesting because it's more narrowly scoped than Federato's RiskOps platform or Sixfold's AI Underwriter ambition. Copilot is essentially an underwriting copilot that augments existing workflows rather than replacing them. That scoping creates a faster time to value, which is a real advantage in enterprise insurance sales where multi-year implementations are death. The tradeoff is that as competing platforms expand their capabilities, Kalepa needs to either deepen the moat on data extraction quality or expand the platform footprint without losing the focus that makes it sticky.

Send Technology

Send is the London-based incumbent in the underwriting workbench category, founded in 2017. Where Federato calls itself RiskOps and positions against the traditional workbench, Send leans into the workbench label and emphasizes deep configurability for commercial insurers and MGAs. The platform serves the broader European and Lloyd's market more heavily than the US, and has historically been less aggressive in messaging than the US-based AI-native challengers.

Send's challenge is the same one facing any platform that built its narrative before the AI-native wave. The workbench category was a legitimate market, but its narrative power has eroded as the AI-native players have repositioned the conversation. Send has been adding AI capabilities, but the platform needs to either accelerate its AI narrative or lean further into the configurability and depth that have been its historical strengths. The acquisition rumors that periodically circulate around mature workbench vendors are not coincidental.

Cytora and the Acquisition Path

Cytora, founded in London in 2014, built a digital intake platform that digitized submissions, enriched them with external data, evaluated them against business rules, and routed them appropriately. Customer roster included Allianz, Chubb, Starr, and Beazley. The company raised approximately $43 million across multiple rounds. In September 2025, Cytora was acquired by Applied Systems, the broker management system giant. The acquisition tells you something important about where the category is heading: the intake layer is consolidating into broader distribution and PAS platforms, and the standalone intake category is shrinking.

This is the acquisition path that several of the 21 vendors in the Datos Insights navigator will follow in the next 24 months. Some will be absorbed into PAS platforms like Guidewire or Duck Creek. Some will be absorbed into broker platforms like Applied or Vertafore. Some will be absorbed by carriers looking to own their underwriting infrastructure. A few will scale into independent category leaders. Most will not.

Indico Data

Indico Data, founded in 2013 in Boston, has built an intake and orchestration platform that ingests, enriches, and orchestrates messy submission packets into complete, validated work. The company's customer testimonials include statements from a CTO at a top 10 global insurance carrier reporting a 50 percent increase in net written premium without expanding the team, attributed to Indico's decisioning efficiency. Convex Insurance has spoken publicly about Indico's role in improving FNOL quality.

Indico has positioned itself as enterprise infrastructure rather than an AI startup, which is a smart play in a market where AI fatigue is starting to become a real factor in procurement conversations. The platform serves both underwriting and claims, which gives it a broader footprint than pure-play underwriting platforms and creates more cross-sell opportunities inside an enterprise account.

Pibit.AI, Convr, IntellectAI, and the Next Wave

Beyond the established players, there's a wave of newer entrants making serious noise. Pibit.AI is a Y Combinator-backed company that claims its CURE platform delivers 85 percent faster underwriting, a 32 percent increase in gross written premium per underwriter, and up to 700 basis points of loss ratio improvement. The metrics are aggressive, and the customer base is reported to span dozens of US clients. The platform's positioning emphasizes agentic underwriting services that convert submissions into decisions.

Convr, based in Schaumburg, Illinois, has been in the modularized underwriting workbench space for nearly a decade. The platform combines data enrichment, risk scoring, and document processing, serving commercial P&C carriers, reinsurers, MGAs, and underwriters. Convr is one of the more mature players in the category and has been quietly building a credible book of business while the higher-profile AI-native challengers have absorbed most of the press attention.

IntellectAI, with its Magic Submission product, has positioned itself at the intake and document intelligence layer. Sapiens AdvantageGo serves the London and global specialty markets with a focus on broker submission and underwriting workflow. Mea Platform has been gaining traction with London market insurers. Each of these vendors is competing for a slice of the same buyer attention, with overlapping capabilities and increasingly similar marketing narratives.

From a product strategy perspective, what's happening here is predictable. When a category gets crowded and capabilities converge, the differentiation moves from features to operating model fit. The vendors that win the next phase of this market will be the ones whose product roadmap, deployment model, integration depth, and customer success motion align tightly with how MGAs and carriers actually operate. That's a product and go-to-market problem, not a technology problem.

How These Decisions Actually Get Made: Four Stories From the Field

Before we get into the buyer constraints framework, it’s worth grounding this in what actually happens when MGAs and carriers evaluate underwriting AI in practice. I’ve walked alongside enough of these decisions to know that the published case studies almost never capture the real dynamics at play. The vendor versions are too clean. The procurement versions are too narrow. What follows is composite from the work I do with operators every week, drawn from real engagements but anonymized to protect specifics. Each one illustrates a different version of the same underlying problem: how to choose the right platform for the right operating context.

The Specialty Casualty MGA Caught Between Three Vendors

A specialty casualty MGA writing roughly $200 million in gross written premium across a handful of E&S programs was running parallel evaluations across three vendors in this category. One was a portfolio-and-workbench platform. One was an AI augmentation tool. One was a pricing and rating decision platform. The principal called me because their procurement process had stalled, and the underwriting team was split on which platform to advance to a paid pilot.

The actual problem was that they were trying to solve three different problems with one platform decision. They had a submission triage problem, a portfolio aggregation problem, and a pricing model versioning problem. Each vendor solved one of those well and the others poorly. I walked them through separating the three problems explicitly, mapping each vendor against the specific problem it was strongest at, and then making a sequenced decision rather than a single platform choice. They ended up running a paid pilot on the AI augmentation tool for triage, kept their existing pricing approach for the near term, and parked the portfolio decision until they had cleaner data infrastructure in place. The cost savings versus a full-stack platform commitment funded a senior underwriting hire that mattered more for their growth than any platform feature would have.

The lesson here is the one I open every MGA conversation with now. Most platform decisions get derailed because the buyer hasn’t separated the layers of the underwriting stack before they start evaluating vendors. The vendors are happy to talk about everything they can do. The buyer’s job is to know exactly which problem they need solved first.

The Mid-Sized Regional Carrier With Capacity Partner Pressure

A mid-sized regional carrier with strong commercial lines presence had spent eighteen months evaluating underwriting platforms. They had narrowed to two finalists. Both demoed well. Both had real customer references. Both came in at comparable pricing. The CFO was ready to sign. The chief underwriting officer pulled me in for a final read because something felt off and she couldn’t articulate what.

What was off was the reinsurance angle. The carrier ceded a meaningful share of their book to two reinsurers, and neither reinsurer had been in any of the evaluation conversations. When I asked the chief underwriting officer how the platform’s exposure aggregation outputs would map to her treaty bordereau requirements, she didn’t have a clean answer. Neither did the vendors. We paused the decision, brought the lead reinsurer’s treaty team into a working session, and discovered that one of the two finalists would have required six months of custom integration work to produce treaty-compliant outputs. The other had built capacity partner alignment into their core data model from the start.

The carrier chose the second platform. The first one would have created treaty renewal headaches that wouldn’t have shown up until eighteen months after deployment, and by then it would have been too late and too expensive to switch. The lesson, which I now build into every carrier evaluation I’m involved with, is that the reinsurance conversation has to happen before the platform decision, not after. Capacity partners are stakeholders in this purchase even when they don’t know it yet.

The Cyber MGA Building a New Program From Scratch

A founder building a cyber MGA from scratch came to me before they had bound their first policy. They had capacity lined up from a top fronting carrier. They had distribution agreements with two national brokers. What they didn’t have was a clear answer on platform strategy. The temptation was to buy the most sophisticated platform on the market to signal seriousness to their capacity partner and to compress their time to market. The actual right answer was the opposite.

For a startup MGA writing under $20 million in early premium, a full-stack underwriting platform is a six to twelve month implementation, a meaningful annual subscription, and a vendor relationship they cannot easily exit. What they actually needed was an AI augmentation layer that could plug into a leaner underwriting workflow, paired with a serious investment in their data infrastructure and broker portal. We mapped a phased platform strategy that started with submission intake automation, layered in AI-assisted risk research in month six, and held the portfolio-and-workbench decision until they crossed $50 million in premium and had enough operating data to evaluate platforms against their actual book rather than a hypothetical one.

The capacity partner respected the discipline. The MGA hit their first-year premium target. The platform decision they eventually made was better-informed because it was made later, against real data, by a team that had operating reps on the underlying workflows. Early-stage MGAs consistently overbuy platform capacity. The right move is almost always to stay lean longer than feels comfortable.

The National Carrier’s Internal Build Versus Buy Debate

A national carrier with several billion in direct written premium was in the middle of an internal debate about whether to build their underwriting AI in-house or partner with a vendor. The data science team wanted to build. The underwriting leadership wanted to buy. The CIO was caught in the middle. I came in to help structure the decision, not to advocate for either side.

The honest answer was both, sequenced correctly. The carrier had real data science capability, real proprietary data, and real reason to want internal control of certain decisioning logic. They also had no realistic chance of building the document ingestion, broker portal, partner integration, and workflow orchestration layers in less than three years, by which point the market would have moved past them. The right structure was to buy the workflow and intake layer from a credible vendor, build the proprietary scoring and decisioning logic in-house, and architect the integration so the internal models plugged into the vendor platform rather than competing with it.

This is the build-versus-buy answer I give carriers consistently now. The platform layer is increasingly commodity infrastructure. The differentiating intelligence sits in the carrier’s own data and models. Vendors that resist this architectural reality and try to lock buyers into proprietary AI black boxes will lose the largest accounts to a hybrid approach. Vendors that embrace it and build for interoperability will become the default infrastructure layer for the next generation of carrier AI strategies.

Four stories, four different decisions, one common thread. The platform that wins is the one that fits the buyer’s actual operating context, not the one with the most advanced demo. That context is shaped by capacity partners, distribution economics, internal capability, premium scale, and lifecycle stage. None of those factors show up in a vendor pitch deck. All of them determine whether the deployment succeeds or fails. With that grounding in place, let’s walk through the five constraints that filter every one of these decisions.

What MGAs and Carriers Are Actually Buying

Here is where most of the analysis goes off the rails. Insurtech coverage tends to focus on the technology stack: agentic AI, federated data graphs, reinforcement learning, large language model fine-tuning. Those things matter, but they are not what MGAs and carrier underwriting teams are buying. They are buying outcomes that fit inside the constraints of their existing business. The constraints are what matter, and a vendor that can map their product narrative to these constraints in the buyer's own language will outperform a technically superior vendor that cannot.

Constraint One: Capacity Alignment

Every MGA platform decision is filtered through the question of whether the platform output will be acceptable to the capacity partner. This is the single most underrated factor in insurtech sales. A platform that produces beautiful underwriting workflows but doesn't integrate with the data formats, reporting cadences, and audit trails that fronting carriers and reinsurers require will fail at the procurement stage even after a successful pilot. The buyer doesn't always articulate this constraint upfront, because they assume the vendor understands it. The vendor often doesn't.

This is also where the product side of the equation gets interesting. When I've built platforms for this market, the integration layer with capacity partners is one of the first architectural decisions, not one of the last. Bordereau reporting, treaty-specific data feeds, exposure aggregation rollups, claims reporting cadences, and the formats that reinsurers expect should be baked into the platform from day one, not bolted on after the first MGA customer complains. Vendors that treat capacity integration as a customer-specific configuration project rather than core platform infrastructure systematically lose deals to vendors that have built it in.

Constraint Two: Distribution Economics

MGAs and specialty carriers live and die by submission flow. The platforms that win are the ones that demonstrably improve broker engagement, submission quality, and bind ratio on the right business. Vertafore's MGA outlook for 2025 named operational cost, profitability, talent, growth, and severe weather as the top five priorities. Underwriting workflow efficiency matters because it sits underneath all five. A 90 percent improvement in time to quote is interesting. A 90 percent improvement in time to quote that also produces a 3x lift in good business bound is a budget conversation.

The platforms that understand distribution economics also understand that broker workflow is part of the platform, not a separate problem. If the partner portal is clunky, brokers will route submissions elsewhere regardless of how elegant the underwriting workflow is on the carrier side. Federato has built a partner portal into RiskOps for this reason. Send has invested in broker submission experience. The vendors that treat broker UX as an afterthought will lose to the ones that treat it as core.

Constraint Three: Integration Depth

The buyer doesn't want another single sign-on tile. They want a platform that pulls from their PAS, their CRM, their broker portal, their reinsurance treaty system, their loss data, and their third-party data enrichment partners. Integration depth is what separates the workbench-and-portfolio platforms from the intake-and-triage point solutions. It's also what determines whether the platform scales beyond the first deployment or stays trapped in a single business unit forever.

This is where strategic partnerships matter operationally, not just optically. Sixfold's strategic investment from Guidewire is meaningful because Guidewire integration is a procurement and deployment unlock for a huge percentage of the P&C market. Cytora's acquisition by Applied makes the platform a default option inside the Applied broker management universe. Standalone vendors without these distribution and integration moats face longer sales cycles and harder expansion conversations, even when their underlying technology is excellent.

Constraint Four: Talent Augmentation

Underwriting talent is the binding constraint in this industry. Senior underwriters are retiring faster than they can be replaced. The platforms that win are the ones that make junior underwriters productive faster, give senior underwriters more leverage, and let an underwriting team handle more submissions without sacrificing selection discipline. This is not the same as automation. Automation that produces faster decisions on the wrong accounts is worse than slower decisions on the right ones.

Sixfold's positioning around the AI Underwriter is sharp on this dimension. Their framing is that operations run on the AI and strategy runs on the people. That's exactly the narrative that underwriting directors are receptive to, because it doesn't threaten the senior underwriter's identity. It augments it. Kalepa's Copilot framing works the same way. The platforms that position themselves as replacing underwriters lose. The platforms that position themselves as multiplying underwriter capacity win. This is a product positioning lesson that most insurtech founders have to learn the hard way, usually after losing several enterprise deals to a competitor that figured it out first.

Constraint Five: Governance and Auditability

Every underwriting decision needs to be explainable, reproducible, and auditable. Regulators are paying attention to algorithmic underwriting in ways that will only intensify. State insurance commissioners are asking questions about model transparency, adverse impact, and decision documentation. A platform that surfaces decisions without explaining them, or that hides its logic inside proprietary AI, creates regulatory and reputational risk the buyer doesn't want.

Sixfold has built explainability into its agent architecture, with traceability of source citations so underwriters can see exactly where information came from. hyperexponential's code-first approach inherently produces auditable pricing logic. Kalepa cites explainability as a core product principle. The vendors that have built this in from the architecture level will win the next phase of the regulatory conversation. The ones that treat explainability as a future roadmap item will lose deals to procurement and compliance teams who increasingly have veto authority over platform decisions.

The Capital Concentration Risk and What Comes Next

Two-thirds of insurtech funding in 2025 went to AI-focused companies. The number of investors making four or more insurtech deals fell to its lowest level since 2017. CB Insights has flagged this as a narrowing investor base that could shrink the innovation pipeline for incumbents who wait too long to engage. Gallagher Re has been direct about the risk: if AI-powered underwriting and claims platforms cannot demonstrate measurable ROI within an 18-month window, the current concentration of capital may start to look less like strategic conviction and more like herd behavior.

That's the question every underwriting platform vendor needs to answer in the next 12 to 24 months. Federato's $100 million Series D buys runway and credibility, but it also raises the bar. A company that raised at a strong Series D valuation against a backdrop of insurtech sobriety is now operating with the expectations of a category leader. Category leaders need to demonstrate not just feature parity but durable customer outcomes, expanding wallet share, and a clear path to either an IPO-ready financial profile or a strategic acquisition at a defensible multiple. The Series D clock is ticking.

hyperexponential operates with similar expectations after its Series B from Battery Ventures and earlier rounds from Highland Europe. Sixfold's $52 million across three rounds is meaningful capital that comes with growth expectations. Kalepa, Send, Indico, Convr, Pibit, IntellectAI, and the other named players are each navigating their own capital concentration risk in ways that depend on their stage, burn rate, and customer expansion velocity.

The other vendors in the category have to make a parallel choice. They can specialize into a defensible niche, accept acquisition by a larger platform or carrier, or compete head-to-head against the better-capitalized players. The first two paths are common. The third is brutal. We will see consolidation in this category over the next 24 months, and the consolidation will favor the vendors with the strongest enterprise sales motions and the deepest integration moats, not necessarily the most advanced technology. Cytora's path into Applied is the template for several upcoming transactions.

What Smart Buyers Are Doing Right Now

If I were running underwriting strategy at a carrier or sitting in the principal seat at an MGA right now, here's how I'd be thinking about platform investments. This is the operating playbook, distilled from a decade of sitting on both sides of these conversations.

First, separate the intake problem from the portfolio problem from the pricing problem. These are three different categories of platform decision, even though several vendors claim to address all three. Indico and Cytora-now-Applied are intake plays. Federato is portfolio and workbench. hyperexponential is pricing. Sixfold and Kalepa are AI augmentation across the underwriting workflow. The most disciplined buyers are evaluating each layer of the underwriting stack independently and being explicit about which problem they are solving. Bundled solutions can be efficient, but they can also create vendor lock-in that becomes painful three years in. Best-of-breed approaches are harder to integrate but preserve optionality.

Second, prioritize platforms that demonstrate measurable outcomes against your own portfolio, not their generic reference customers. The 90 percent time-to-quote improvement that a vendor cites is a starting point. The relevant question is what time-to-quote improvement that platform delivers on submissions that match your appetite, in your distribution channel, with your underwriting standards. Vendors that resist running a structured pilot against your own data are vendors that don't have confidence in their own claims. The platforms that have figured out how to run efficient, time-boxed pilots will outperform the ones that drag every evaluation into a six-month proof of concept.

Third, evaluate the enterprise sales team and customer success function as carefully as you evaluate the product. The platforms that succeed in your environment will be the ones whose teams can navigate your organization, build alignment across underwriting, IT, compliance, and finance, and deliver consistent execution after the contract is signed. A great product with a weak sales and service motion will underperform a good product with a strong one, every time. I have seen this play out in dozens of evaluations, and the pattern is remarkably consistent. The team in the room matters as much as the product on the screen.

Fourth, push for explainability and auditability from day one. Don't accept proprietary AI as a black box. Ask how decisions are documented, how models are validated, how adverse impact is monitored, and how the platform supports regulatory reporting. The vendors that have built this in will answer the questions cleanly. The ones that haven't will either dodge or improvise. That's diagnostic.

Fifth, think hard about the capacity partner conversation. If you're an MGA, talk to your reinsurer before you sign the contract, not after. If you're a carrier, talk to your reinsurance treaty lead. Platform decisions that don't account for capacity dynamics get expensive in renewal cycles in ways that aren't always obvious upfront. The platforms that have invested in capacity partner alignment as core product infrastructure will save you these headaches. The ones that haven't will create them.

Sixth, think about the integration story explicitly. Where does the platform sit relative to your PAS? Your CRM? Your broker portal? Your data enrichment partners? Your bordereau reporting? The platforms that have built first-class integrations into the systems you already rely on will deploy in months. The ones that haven't will deploy in years, or never. Sixfold's Guidewire alignment, Cytora's Applied integration, and the various Salesforce-adjacent platforms all have meaningful advantages on this dimension that buyers should weight accordingly.

The Takeaway

The insurtech market in 2026 is not the insurtech market of 2021. The capital has shifted, the buyer has shifted, the competitive landscape has shifted, and the bar for what counts as a successful platform has shifted with all of it. The companies raising mega-rounds today are building infrastructure for incumbent carriers and MGAs, not disrupting them. The buyers writing the checks are sophisticated operators with specific constraints around capacity, distribution, integration, talent, and governance. The vendors that win are the ones whose product roadmap and enterprise sales motions actually speak to those constraints in the buyer's own language.

Federato, hyperexponential, Sixfold, Kalepa, Send, Indico, Convr, and the broader field of 21 named workbench vendors are each navigating this transition with different strengths and different exposures. Federato has the most aggressive positioning narrative and the deepest pool of recent capital. hyperexponential has the strongest pricing platform in specialty and the most credible Lloyd's market footprint. Sixfold has the most operationally proven AI augmentation deployments at scale. Kalepa has the cleanest copilot product and a credible specialty customer base. Cytora has chosen the acquisition path and joined Applied. Several others will follow Cytora's path over the next 24 months. A small handful will scale into independent category leaders. Most will not.

The vendors that succeed will be the ones who understood from the start that the technology was always the easier part of the equation. The harder part was always selling to a buyer who is more sophisticated than the market gives them credit for, with constraints that don't fit neatly into a venture pitch deck, and with timelines that don't match a quarterly board review. The vendors who learn that lesson early will own the next decade of this market. The ones who don't will become acquisitions, footnotes, or cautionary tales.

For the MGAs and carriers making platform decisions right now, the operating playbook is clear. Separate the layers of the stack. Run real pilots against your own data. Evaluate the team alongside the product. Demand explainability. Talk to your capacity partners. Think about integration depth before you sign. The market is mature enough now that you can find a platform for almost any underwriting problem you face. The skill is in matching the right platform to the right problem in your specific operating context, and in choosing a vendor whose company you can live with for the next five years.

That's the state of the insurance tech market in 2026. The opportunity is real. The capital is real. The buyer sophistication is real. What remains to be seen is which vendors can actually close the gap between what they think they're selling and what their customers are actually buying. The ones who close that gap will define the category for the next decade. The ones who don't are running out of time to figure it out.

Fabio Faschi is an Insurance Product and Sales leader, National Producer, Board Member of the Young Risk Professionals New York City chapter and Committee Chair at RISE with over a decade of experience in the insurance industry. He has built and scaled over a dozen national brokerages and SaaS-driven insurance platforms, and is the founder of ScholarusAI.com and Hogglet.com for Enterprise AI transformation and risk management. Fabio's expertise has been featured in publications like Forbes, Consumer Affairs, Realtor.com, Apartment Therapy, SFGATE, Bankrate and Lifehacker.